Auspherix raises $1 mn for antibiotics

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2014

Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...Read more

Clinuvel's subisidiary develops drug candidate for vitiligo

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 May, 2015

Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...Read more

EU supports Pyridorin drug trial for diabetic nephropathy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2015

Singapore: NephroGenex, pharmaceutical company focused on the development of therapeutics to treat kidney disease, has r...Read more

EMA to review Eli Lilly's basal insulin

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: European Medicines Agency (EMA) has accepted Eli Lilly and Boehringer Ingelheim's marketing authorisation app...Read more

Novartis' Cosentyx receives Japanese nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2015

Singapore: The Japanese Ministry for Health and Welfare has recently given its nod for Novatris' Cosentyx, that treats p...Read more

Aus invests $1mn in antibiotics start-up Auspherix

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2013

Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...Read more

Japanese scientists identify genes associated with peripheral artery disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Oct, 2015

Tokyo: Researchers from the RIKEN Center for Integrative Medical Sciences have worked with a number of universities and...Read more

Swedish firm partners with Sanofi to expand in Asia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's a...Read more

WuXi CRO gets toxicity prediction software license

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...Read more

Asthma therapy market to touch $23.1 bn by 2023

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 6 Comment | 08 Sep, 2014

Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...Read more

Nemus' glaucoma drug secures patent in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Oct, 2015

Nemus Bioscience Inc. has announced that the pro-drug of tetrahydrocannabinol (THC) in-licensed from the company's resea...Read more

Israel firm to develop epilepsy drug in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Apr, 2015

Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...Read more

UK pours $500 mn in genome sequencing

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2014

Singapore:  In a move to accelerate genome sequencing and bring breakthrough in cancer treatment in the country, UK has...Read more

Mochida seeks Ulcerative Colitis drug approval in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2015

Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...Read more

Sanofi terminates NaP2b inhibitors development deal with Ardelyx

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2015

Singapore: Sanofi has terminated NaP2b inhibitors development deal with US based Ardelyx, a clinical-stage biopharmaceut...Read more

AB SCIEX, Dalton Pharma to advance antibody drug conjugate analysis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2014

Singapore: Global technology firm AB SCIEX and Dalton Pharma Services have formed a research collaboration to develop An...Read more

Profits - A stumbling block for Ebola research

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2014

Singapore: Global experts have commented that the lack of adequate funding was a major drawback that discouraged researc...Read more

Aussie firm to initiate oncology clinical trial in Europe

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2014

Singapore: Australia based drug discovery company, Viralytics, has recieved UK Medicines and Healthcare Products Regulat...Read more